IL22 and Alzheimer disease: Interestingly, the decreased IL-22 secretion by CD4+ T cells is reinforced by previous data that showed inhibited statuses in both the antigen-specific proliferative response and polyclonal activators28 in AD, suggesting a suppressed profile of CD4+ T cells in AD patients, corroborated by reduced cytokine secretion after stimulation.